AbbVie releases phase 3 induction therapy data on injectable Skyrizi for Crohn's
Related news
-
Apple’s HomeView brings personalized Siri to smart home, takes on Amazon and Google
-
AJB Investment Fund II buys $35,619 in Jewett Cameron Trading Co shares
-
Citi Trends VP of HR Katrina George sells $25,285 in stock
-
Distribution Solutions Group to acquire GradeEight Holdings for $110M
-
HII wins $56M Navy contract for AUKUS submarine support
-
Fed Governor Cook’s lawyer denounces Trump’s latest attempt to remove her
-
Workday director David Duffield sells $18.7m in company stock
-
Williams Sonoma EVP Karalyn Yearout sells $124,945 in stock